{"id":"https://openalex.org/W7204701788","doi":"https://doi.org/10.1016/s2152-2650(26)01116-x","title":"POSTER: ABCL-736: Outpatient Treatment With Glofitamab Plus Gemcitabine and Oxaliplatin in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Preliminary Safety Results From a Phase 2 Study","display_name":"POSTER: ABCL-736: Outpatient Treatment With Glofitamab Plus Gemcitabine and Oxaliplatin in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Preliminary Safety Results From a Phase 2 Study","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204701788","doi":"https://doi.org/10.1016/s2152-2650(26)01116-x"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(26)01116-x","doi":"https://doi.org/10.1016/s2152-2650(26)01116-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)01116-x","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022379369","display_name":"Dok Hyun Yoon","orcid":"https://orcid.org/0000-0002-8289-3548","observed_orcids":["https://orcid.org/0000-0002-8289-3548"]},"institutions":[{"id":"https://openalex.org/I2801680663","display_name":"Asan Medical Center","ror":"https://ror.org/03s5q0090","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2801680663","https://openalex.org/I4210167194"]},{"id":"https://openalex.org/I40542001","display_name":"University of Ulsan","ror":"https://ror.org/02c2f8975","country_code":"KR","type":"education","lineage":["https://openalex.org/I40542001"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Dok Hyun Yoon","raw_affiliation_strings":["University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Republic of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Republic of","institution_ids":["https://openalex.org/I2801680663","https://openalex.org/I40542001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5137147023","display_name":"David Berz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Berz","raw_affiliation_strings":["Valkyrie Clinical Trials, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Valkyrie Clinical Trials, Los Angeles, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042459008","display_name":"Carmelo Carlo\u2010Stella","orcid":"https://orcid.org/0000-0003-3144-0124","observed_orcids":["https://orcid.org/0000-0003-3144-0124"]},"institutions":[{"id":"https://openalex.org/I1339471597","display_name":"Humanitas University","ror":"https://ror.org/020dggs04","country_code":"IT","type":"education","lineage":["https://openalex.org/I1339471597"]},{"id":"https://openalex.org/I4210163047","display_name":"IRCCS Humanitas Research Hospital","ror":"https://ror.org/05d538656","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210163047"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Carmelo Carlo-Stella","raw_affiliation_strings":["Humanitas University and Department of Oncology and Hematology, Humanitas Research Hospital, Rozzano-Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Humanitas University and Department of Oncology and Hematology, Humanitas Research Hospital, Rozzano-Milano, Italy","institution_ids":["https://openalex.org/I1339471597","https://openalex.org/I4210163047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111903747","display_name":"Rami R. Kotb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088414","display_name":"CancerCare Manitoba","ror":"https://ror.org/005cmms77","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4210088414"]},{"id":"https://openalex.org/I46247651","display_name":"University of Manitoba","ror":"https://ror.org/02gfys938","country_code":"CA","type":"education","lineage":["https://openalex.org/I46247651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Rami Kotb","raw_affiliation_strings":["CancerCare Manitoba and University of Manitoba, Winnipeg, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CancerCare Manitoba and University of Manitoba, Winnipeg, Canada","institution_ids":["https://openalex.org/I4210088414","https://openalex.org/I46247651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148713745","display_name":"Jeong-Ok Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]},{"id":"https://openalex.org/I2803058125","display_name":"Seoul National University Bundang Hospital","ror":"https://ror.org/00cb3km46","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I139264467","https://openalex.org/I2802835388","https://openalex.org/I2803058125"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Jeong-Ok Lee","raw_affiliation_strings":["Seoul National University Bundang Hospital, Seoul National University College of Medicine Seongnam, Seoul, Korea, Republic of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seoul National University Bundang Hospital, Seoul National University College of Medicine Seongnam, Seoul, Korea, Republic of","institution_ids":["https://openalex.org/I139264467","https://openalex.org/I2803058125"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045486705","display_name":"Charles Herbaux","orcid":"https://orcid.org/0000-0003-4910-476X","observed_orcids":["https://orcid.org/0000-0003-4910-476X"]},"institutions":[{"id":"https://openalex.org/I4210093292","display_name":"Centre Hospitalier Universitaire de Montpellier","ror":"https://ror.org/00mthsf17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Charles Herbaux","raw_affiliation_strings":["University Hospital of Montpellier, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital of Montpellier, Montpellier, France","institution_ids":["https://openalex.org/I4210093292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075203908","display_name":"Robert Puckrin","orcid":"https://orcid.org/0000-0002-8918-6598","observed_orcids":["https://orcid.org/0000-0002-8918-6598"]},"institutions":[{"id":"https://openalex.org/I168635309","display_name":"University of Calgary","ror":"https://ror.org/03yjb2x39","country_code":"CA","type":"education","lineage":["https://openalex.org/I168635309"]},{"id":"https://openalex.org/I4405273471","display_name":"Arthur J.E. Child Comprehensive Cancer Centre","ror":"https://ror.org/05w495036","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I126859394","https://openalex.org/I4405273471"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Robert Puckrin","raw_affiliation_strings":["University of Calgary, Arthur Child Comprehensive Cancer Centre, Calgary, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Calgary, Arthur Child Comprehensive Cancer Centre, Calgary, Canada","institution_ids":["https://openalex.org/I168635309","https://openalex.org/I4405273471"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054178326","display_name":"Vanja Zeremski","orcid":"https://orcid.org/0000-0002-5254-9885","observed_orcids":["https://orcid.org/0000-0002-5254-9885"]},"institutions":[{"id":"https://openalex.org/I95793202","display_name":"Otto-von-Guericke-Universit\u00e4t Magdeburg","ror":"https://ror.org/00ggpsq73","country_code":"DE","type":"education","lineage":["https://openalex.org/I95793202"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Vanja Zeremski","raw_affiliation_strings":["Otto von Guericke University Magdeburg, Magdeburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otto von Guericke University Magdeburg, Magdeburg, Germany","institution_ids":["https://openalex.org/I95793202"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079982914","display_name":"Lucile Bussot","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lucile Bussot","raw_affiliation_strings":["Daniel-Hollard Institute, Grenoble, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Daniel-Hollard Institute, Grenoble, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082964368","display_name":"Gerardo Musuraca","orcid":"https://orcid.org/0000-0003-1947-1032","observed_orcids":["https://orcid.org/0000-0003-1947-1032"]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gerardo Musuraca","raw_affiliation_strings":["IRCCS -, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori \u201cDino Amadori\u201d Srl, Meldola, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IRCCS -, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori \u201cDino Amadori\u201d Srl, Meldola, Italy","institution_ids":["https://openalex.org/I4210097834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040698513","display_name":"Ritika Jagtiani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ritika Jagtiani","raw_affiliation_strings":["Genentech, Inc, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148661089","display_name":"Juana Hernandez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Juana Hernandez","raw_affiliation_strings":["F Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148666924","display_name":"Grace Smithen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Grace Smithen","raw_affiliation_strings":["F Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032720171","display_name":"Isabel Prieto Gonz\u00e1lez-Albo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113058","display_name":"Roche (United Kingdom)","ror":"https://ror.org/024tgbv41","country_code":"GB","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210113058"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Isabel Prieto Gonzalez-Albo","raw_affiliation_strings":["Roche Products Ltd, Welwyn Garden City, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Products Ltd, Welwyn Garden City, United Kingdom","institution_ids":["https://openalex.org/I4210113058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068887623","display_name":"Linda Lundberg","orcid":"https://orcid.org/0009-0000-4654-559X","observed_orcids":["https://orcid.org/0009-0000-4654-559X"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Linda Lundberg","raw_affiliation_strings":["F Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074259260","display_name":"James Relf","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"James Relf","raw_affiliation_strings":["F Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061916244","display_name":"John M. Burke","orcid":"https://orcid.org/0000-0002-5144-6710","observed_orcids":["https://orcid.org/0000-0002-5144-6710"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210140702","display_name":"Rocky Mountain Cancer Centers","ror":"https://ror.org/03ynhs115","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210140702"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John M Burke","raw_affiliation_strings":["Sarah Cannon Research Institute (SCRI) at Rocky Mountain Cancer Centers, Aurora, CO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute (SCRI) at Rocky Mountain Cancer Centers, Aurora, CO, USA","institution_ids":["https://openalex.org/I4210100810","https://openalex.org/I4210140702"]}]}],"institutions":[],"countries_distinct_count":8,"institutions_distinct_count":18,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":null,"first_page":"S307","last_page":"S307"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glofitamab","display_name":"glofitamab","score":0.9639999866485596},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9399999976158142},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":1.0},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9160000085830688},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.9850000143051147},{"id":"https://openalex.org/keywords/outpatient-care","display_name":"outpatient care","score":0.8640000224113464},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.7269999980926514}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.98089998960495},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.8256000280380249},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.7792999744415283},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6796000003814697},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6671000123023987},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.5224999785423279},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.35010001063346863},{"id":"https://openalex.org/C3020110884","wikidata":"https://www.wikidata.org/wiki/Q695416","display_name":"Outpatient clinic","level":2,"score":0.3458999991416931},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.29600000381469727},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.24699999392032623}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(26)01116-x","doi":"https://doi.org/10.1016/s2152-2650(26)01116-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)01116-x","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7204693687","https://openalex.org/W4386270833","https://openalex.org/W4413810210","https://openalex.org/W4413810870","https://openalex.org/W4413787554","https://openalex.org/W4413777401","https://openalex.org/W4413791486","https://openalex.org/W7204695611","https://openalex.org/W4386277971","https://openalex.org/W4386281990"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-08-31T00:00:00"}